https://doi.org/10.1038/nature12634
M
Mingchao Xie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
9.2K
Citations
17
h-index
17
i10-index
Mingchao Xie is an academic researcher from AstraZeneca (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics & Epigenetics and DNA Methylation. The author has an h-index of 17, co-authored 53 publications.
Papers by this author
worksMutational landscape and significance across 12 major cancer types
2013 · Nature · 4,422 citations
DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape
2013 · Nature Genetics · 243 citations
https://doi.org/10.1038/ng.2649
Divergent viral presentation among human tumors and adjacent normal tissues
2016 · Scientific Reports · 76 citations
https://doi.org/10.1038/srep28294
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer
2025 · Molecular Cancer · 2 citations
https://doi.org/10.1186/s12943-025-02514-4
299P: First-line (1L) durvalumab (D) + platinum-etoposide (EP) in extensive-stage SCLC (ES-SCLC): Final results and exploratory biomarker analyses from LUMINANCE
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/s1556-0864(25)00491-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat